Cipla Ltd.

Cipla’s wholly owned step down subsidiary -Meditab Holdings (MHL) has acquired an additional 14.5% stake in Quality Chemical Industries (QCIL), Uganda for a consideration of USD 15 million. QCIL’s principal activity is manufacturing and selling of pharmaceutical drugs with emphasis on anti-retroviral (ARV’s) and anti-malarial drugs. QCIL has a WHO approved manufacturing facility in Uganda.

MHL was earlier holding 36.55% stake in QCIL. Consequent to the acquisition of aforesaid additional stake, MHL now holds 51.05% stake in QCIL.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.